CLINICAL_TRIALS
trial_result
· 2021-04-01
Clinical Trial Update: A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301) [Phase 3]
Summary
Phase 3 clinical trial update for IDP-123 Lotion in acne vulgaris has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bausch Health Americas, Inc. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED | Results posted: 2021-04-01